A simple strategy for retargeting lentiviral vectors to desired cell types via a disulfide-bond-forming protein-peptide pair

Scientific Reports
Nagarjun KasaraneniZhilei Chen

Abstract

Despite recent improvements in the engineering of viral envelope proteins, it remains a significant challenge to create lentiviral vectors that allow targeted transduction to specific cell populations of interest. In this study, we developed a simple 'plug and play' strategy to retarget lentiviral vectors to any desired cell types through in vitro covalent modification of the virions with specific cell-targeting proteins (CTPs). This strategy exploits a disulfide bond-forming protein-peptide pair PDZ1 and its pentapeptide ligand (ThrGluPheCysAla, TEFCA). PDZ1 was incorporated into an engineered Sindbis virus envelope protein (Sind-PDZ1) and displayed on lentiviral particles while the TEFCA pentapeptide ligand was genetically linked to the CTP. Her2/neu-binding designed ankyrin repeat proteins (DARPin) were used as our model CTPs. DARPin-functionalized unconcentrated lentiviral vectors harboring Sind-PDZ1 envelope protein (Sind-PDZ1-pp) exhibited >800-fold higher infectious titer in HER2+ cells than the unfunctionalized virions (8.5 × 106 vs. <104 IU/mL). Moreover, by virtue of the covalent disulfide bond interaction between PDZ1 and TEFCA, the association of the CTP with the virions is nonreversible under non-reducing condition...Continue Reading

References

Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M K GornyS Zolla-Pazner
Sep 14, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·N J DePoloT W Dubensky
Aug 3, 2001·Journal of Virology·K MorizonoI S Chen
May 1, 2007·Journal of Molecular Biology·Christian ZahndAndreas Plückthun
Jul 27, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nonia ParienteIrvin S Y Chen
Jun 26, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sabrina FunkeChristian J Buchholz
Aug 19, 2008·Journal of Molecular Biology·Daniel SteinerAndreas Plückthun
Mar 31, 2009·Trends in Biotechnology·Christian J BuchholzKlaus Cichutek
May 13, 2009·The Journal of Gene Medicine·Kouki MorizonoIrvin S Y Chen
Jan 13, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Robert C MünchChristian J Buchholz
Dec 12, 2012·Protein Engineering, Design & Selection : PEDS·Miguel RamirezZhilei Chen
Feb 6, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Katrin FriedrichMichael D Mühlebach
Apr 17, 2013·Proceedings of the National Academy of Sciences of the United States of America·Danit FinkelshteinMenachem Rubinstein
Jul 23, 2013·Protein Science : a Publication of the Protein Society·Markus A SeegerMarkus G Grütter
Jan 7, 2015·Annual Review of Pharmacology and Toxicology·Andreas Plückthun
Feb 27, 2015·Protein Engineering, Design & Selection : PEDS·Thorsten FriedelIrene C Schneider
Oct 16, 2015·Nature·Luigi Naldini
Oct 27, 2015·Trends in Biotechnology·Christian J BuchholzHildegard Büning
Dec 9, 2015·Annual Review of Biomedical Engineering·Melissa A KottermanDavid V Schaffer

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
flow cytometry

Software Mentioned

Quantity One

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.